Ultrasound-guided Blood Sampling Drawing for Microbiological Analysis in the Critically Ill
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Study ID
- NCT06156072
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Diagnosis
- Infections
- Sepsis
- Septic Shock
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Ultrasound-guided venipuncture — DIAGNOSTIC_TESTVenipuncture will be performed using ultrasound to identify the most appropriate vessel and guide the puncture
Study Details
This study will test the feasibility of ultrasound-guided sterile blood sampling for critically ill patients with suspected sepsis requiring blood culture. The aim of the study is to evaluate the feasibility and safety of the use of ultrasound for blood cultures in a population of patients which can present difficult venous access and requiring more than one venipuncture attempt in general clinical practice
Key Dates
- First listed
- Dec 5, 2023
- Start date
- Jun 30, 2025
- Status verified
- Feb 2025
- Primary completion
- Jun 30, 2025
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: Patient requiring blood cultureAfter the request of treating physician of blood culture, each patient deemed eligible, will undergo the prescirbed couple of peripheral blood samples. The first one will be done with the classical blind technique, while the second one with ultrasound guidance.
Primary Outcome Measure
Number of attempted venipunctures [ Time Frame: One hour after clinical decision of blood culture execution ]
Central Contacts
- Antonio M Dell'Anna, M.D.3803679256
Related Studies
- Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- A Phase I Study of Mozobil in the Treatment of Patients With WHIMSPHASE1/PHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Alveolar Dead Space as Predictor of Organ Failure in Severe SepsisNot Yet Recruiting · The University of Texas Health Science Center, Houston · Houston, Texas
- Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?Recruiting · Michigan State University · Lansing, Michigan